EcoR1 Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Tectonic Therapeutictectonictx.cominFeb 2025 · $185M
Tectonic is a clinical-stage biotechnology company developing therapeutic proteins and antibodies that target G-Protein Coupled Receptors (GPCRs) using a proprietary platform called GEODe™.
AI & Machine LearningBiotechMedical DevicesWatertown, US
Timothy A. Springer(Co-Founder)Andrew C. KruseTimothy Springer(Director)Andrew Kruse(Director)Alise Reicin(Executive Officer, Director)Daniel Lochner(Executive Officer)
Co-investorsVida VenturesAlly Bridge GroupClarusPolaris PartnersSoleus Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.